Medical Properties Trust (MPW) Downgraded by Robert W. Baird

Robert W. Baird lowered shares of Medical Properties Trust (NYSE:MPW) from an outperform rating to a neutral rating in a report released on Friday morning, MarketBeat.com reports. Robert W. Baird currently has $13.00 target price on the real estate investment trust’s stock, down from their prior target price of $15.00.

Other equities analysts have also recently issued reports about the stock. Zacks Investment Research raised shares of Medical Properties Trust from a hold rating to a buy rating and set a $15.00 price objective on the stock in a research note on Tuesday, October 24th. ValuEngine raised shares of Medical Properties Trust from a hold rating to a buy rating in a research report on Monday, October 2nd. SunTrust Banks reissued a buy rating and set a $15.00 price target on shares of Medical Properties Trust in a research report on Friday, November 3rd. KeyCorp reissued a hold rating on shares of Medical Properties Trust in a research report on Sunday, September 17th. Finally, JPMorgan Chase & Co. raised shares of Medical Properties Trust from an underweight rating to a neutral rating and set a $14.50 price target on the stock in a research report on Friday, December 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the company. The company currently has a consensus rating of Hold and an average target price of $14.45.

Shares of Medical Properties Trust (NYSE:MPW) traded up $0.03 during mid-day trading on Friday, reaching $13.31. 3,326,100 shares of the company’s stock were exchanged, compared to its average volume of 2,320,360. Medical Properties Trust has a 1 year low of $11.90 and a 1 year high of $14.22. The company has a market capitalization of $4,820.00, a PE ratio of 17.51, a PEG ratio of 1.64 and a beta of 0.96. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 1.26.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.01. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The firm had revenue of $176.60 million for the quarter, compared to analysts’ expectations of $172.57 million. During the same period last year, the firm earned $0.30 earnings per share. The business’s revenue for the quarter was up 39.5% on a year-over-year basis. analysts forecast that Medical Properties Trust will post 1.33 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 11th. Stockholders of record on Thursday, December 7th will be given a dividend of $0.24 per share. The ex-dividend date of this dividend is Wednesday, December 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.21%. Medical Properties Trust’s dividend payout ratio is 126.32%.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Brown Advisory Inc. raised its holdings in shares of Medical Properties Trust by 22.0% during the third quarter. Brown Advisory Inc. now owns 49,784 shares of the real estate investment trust’s stock worth $653,000 after acquiring an additional 8,968 shares during the period. BlueCrest Capital Management Ltd acquired a new stake in shares of Medical Properties Trust during the second quarter worth $5,349,000. Systematic Financial Management LP acquired a new stake in shares of Medical Properties Trust during the second quarter worth $29,018,000. Goldman Sachs Group Inc. raised its holdings in shares of Medical Properties Trust by 26.5% during the second quarter. Goldman Sachs Group Inc. now owns 2,091,500 shares of the real estate investment trust’s stock worth $26,917,000 after acquiring an additional 438,140 shares during the period. Finally, Shelton Capital Management raised its holdings in shares of Medical Properties Trust by 69.9% during the second quarter. Shelton Capital Management now owns 27,660 shares of the real estate investment trust’s stock worth $356,000 after acquiring an additional 11,382 shares during the period. 81.20% of the stock is currently owned by institutional investors.

WARNING: “Medical Properties Trust (MPW) Downgraded by Robert W. Baird” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.com-unik.info/2018/01/09/medical-properties-trust-mpw-downgraded-by-robert-w-baird.html.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit